Merz GmbH & Co. KGaA Release: Memantine Captures US Market

Namenda's success is a reflection of an unmet need in patients with moderate to severe Alzheimer's disease in the United States. In Europe, memantine (Axura(R)) is established since May 2002 in the same indication.